|Tested species reactivity||Human|
|Published species reactivity||Human, Not Applicable|
|Host / Isotype||Mouse / IgG1|
|Storage buffer||PBS with 10% sucrose, 4mg/ml BSA|
|Contains||0.1% sodium azide|
|Storage Conditions||4° C|
|Tested Applications||Dilution *|
|Flow Cytometry (Flow)||5 ul for 1x10^6 cells|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
|Flow Cytometry (Flow)||See 2 publications below|
CD34 is a highly glycosylated monomeric 111-115 kDa surface protein, which is present on many stem cell populations. It is a well established stem cell marker, though its expression on human hematopoietic stem cells is reversible. CD34 probably serves as a surface receptor that undergoes receptor-mediated endocytosis and regulates adhesion, differentiation and proliferation of hematopoietic stem cells and other progenitors. CD34 expression is likely to represent a specific state of hematopoietic development that may have altered adhering properties with expanding and differentiating capabilities in both in vitro and in vivo conditions.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Inner ear progenitor cells can be generated in vitro from human bone marrow mesenchymal stem cells.
CD34-581-04 was used in flow cytometry to assess the ability of human mesenchymal stem cells to differentiate into otic lineages.
|Boddy SL,Chen W,Romero-Guevara R,Kottam L,Bellantuono I,Rivolta MN||Regenerative medicine (7:757)||2012|
|Not Applicable||Not Cited||
Antigen CD34+ marrow cells engraft lethally irradiated baboons.
CD34-581-04 was used in flow cytometry to propose that stem cells responsible for hematopoietic reconstitution are CD34+
|Berenson RJ,Andrews RG,Bensinger WI,Kalamasz D,Knitter G,Buckner CD,Bernstein ID||The Journal of clinical investigation (81:951)||1988|